Drug
Tab004
Tab004: highest development phase Phase 1, developed by Junshi Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Junshi Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| TAB004 NCT04137900 | Phase 1 | Advanced Unresectable Solid Tumor |
Latest
No recent events.
Follow Tab004 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.